Cvs Health (CVS) Cash from Investing Activities (2009 - 2026)

Cvs Health's Cash from Investing Activities history runs 18 years deep, the most recent figure standing at -$874.0 million for Q1 2026.

• Quarterly Cash from Investing Activities fell 14.7% year-over-year to -$874.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$6.0 billion (up 4.74% YoY) and the FY2025 annual result came in at -$5.9 billion, up 22.88% from the prior year.
• Cash from Investing Activities was -$874.0 million for Q1 2026 at Cvs Health, up from -$2.0 billion in the prior quarter.
• Across five years, Cash from Investing Activities topped out at -$119.0 million in Q4 2022 and bottomed at -$10.4 billion in Q2 2023.
• A 5-year average of -$2.4 billion and a median of -$1.6 billion in 2024 frame the typical range for Cash from Investing Activities.
• Annual changes were most pronounced in 2022 — Cash from Investing Activities soared 91.74% — and 2023, when it sank 943.7%.
• Cvs Health's Cash from Investing Activities stood at -$119.0 million in 2022, then sank by 943.7% to -$1.2 billion in 2023, then jumped by 55.96% to -$547.0 million in 2024, then plunged by 265.27% to -$2.0 billion in 2025, then soared by 56.26% to -$874.0 million in 2026.
• Business Quant data shows CVS's Cash from Investing Activities at -$874.0 million in Q1 2026, -$2.0 billion in Q4 2025, and -$2.1 billion in Q3 2025.